Search - tctmd.com

Displaying 481 - 500 of 806

Sort: Relevancy | Date

Presentation TCT 2015

Debate: Will Bioresorbable Scaffolds Replace Metallic Stents in the Majority of Cases? NO!

Presenter: Carlo Di Mario, Eberhard Grube, Daniel I. Simon

October 11, 2015

Presentation TCT 2015

Debate: Will Bioresorbable Scaffolds Replace Metallic Stents in the Majority of Cases? YES!

Presenter: Carlo Di Mario, Eberhard Grube, Manel Sabate

October 11, 2015

Presentation TCT 2015

Medina 1, 1, 1 of the Distal Left Main: Are 2 Stents Needed?

Presenter: Rabin dra Nath Chakraborty, Angela Hoye

October 11, 2015

Presentation TCT 2015

Case 2: A Case Where Metallic DES Was Preferred Over BVS

Presenter: Carlo Di Mario, Eberhard Grube, Nicolas M. Van Mieghem

October 11, 2015

Presentation TCT 2015

Case 1: A Case Where BVS Was Preferred Over Metallic DES

Presenter: Carlo Di Mario, Eberhard Grube, Azeem Latib

October 11, 2015

Presentation TCT 2015

Case Presentation Before Second-Time Treatment: Recurrent DES Restenosis

Presenter: Robert A. Byrne, Stefan K. James, Wojtek Wojakowski

October 11, 2015

$The Resurrection of Historic Therapies for Refractory Restenosis: Vascular Brachytherapy, Atherectomy, and Beyond$

Presentation TCT 2015

The Resurrection of Historic Therapies for Refractory Restenosis: Vascular Brachytherapy, Atherectomy, and Beyond

Presenter: Robert A. Byrne, Stefan K. James, Paul S. Teirstein

October 11, 2015

Presentation TCT 2015

Drug-Eluting Stent Restenosis State of the Art: Causes, Evaluation, and Treatment

Presenter: Robert A. Byrne, Stefan K. James, Fernando Alfonso

October 11, 2015

Presentation TCT 2015

How Was the Case Treated

Presenter: Robert A. Byrne, Stefan K. James, Ehrin J. Armstrong

October 11, 2015

Presentation TCT 2015

Case Presentation Before Treatment: An Unexpected and Difficult to Treat Stent Thrombosis

Presenter: Robert A. Byrne, Stefan K. James, Ehrin J. Armstrong

October 11, 2015

Presentation TCT 2015

Are There Differences in the Outcomes of Early, Late, and Very Late Stent Thrombosis?

Presenter: Robert A. Byrne, Stefan K. James, Donald Cutlip

October 11, 2015

Presentation TCT 2015

New Insights Into Neoatherosclerosis as a Frequent Common Denominator of DES Failure

Presenter: Robert A. Byrne, Stefan K. James, Renu Virmani

October 11, 2015

Presentation TCT 2015

Stent Thrombosis Update: Causes, Predictors, Implications, and Treatment

Presenter: Robert A. Byrne, Stefan K. James

October 11, 2015

Presentation TCT 2015

How Was This Patient Treated?

Presenter: Kevin J. Beatt, Craig R. Smith, Hemal Gada

October 11, 2015

Presentation TCT 2015

Debate: Should Most Patients With Stable Ischemic Heart Disease, Moderate or Greater Ischemia, and Controllable Symptoms Undergo Revascularization? Yes, an Evidence-Based Position!

Presenter: Kevin J. Beatt, Craig R. Smith, Gregg W. Stone

October 11, 2015

Presentation TCT 2015

Debate: Should Most Patients With Stable Ischemic Heart Disease, Moderate or Greater Ischemia, and Controllable Symptoms Undergo Revascularization? The Data Says Not as a First-Line Therapy!

Presenter: Kevin J. Beatt, Craig R. Smith, David J. Maron

October 11, 2015

Presentation TCT 2015

Case Presentation: Pretreatment A Patient With Class II Angina and Anterior Wall Ischemia

Presenter: Kevin J. Beatt, Craig R. Smith, Hemal Gada

October 11, 2015

Presentation TCT 2015

How the Case Was Treated

Presenter: Kevin J. Beatt, Craig R. Smith, Javier Escaned

October 11, 2015

Presentation TCT 2015

Case Presentation Pretreatment: MVD Disease With Intermediate SYNTAX Score: How Should This Patient Be Treated?

Presenter: Kevin J. Beatt, Craig R. Smith, Javier Escaned

October 11, 2015

Presentation TCT 2015

Assessment and Implications of Surgical Inoperability: Who Is at High Risk?

Presenter: Kevin J. Beatt, Craig R. Smith, Robert W. Yeh

October 11, 2015

Advertisement

Debate: Will Bioresorbable Scaffolds Replace Metallic Stents in the Majority of Cases? NO!

Debate: Will Bioresorbable Scaffolds Replace Metallic Stents in the Majority of Cases? YES!

Medina 1, 1, 1 of the Distal Left Main: Are 2 Stents Needed?

Case 2: A Case Where Metallic DES Was Preferred Over BVS

Case 1: A Case Where BVS Was Preferred Over Metallic DES

Case Presentation Before Second-Time Treatment: Recurrent DES Restenosis

The Resurrection of Historic Therapies for Refractory Restenosis: Vascular Brachytherapy, Atherectomy, and Beyond

Drug-Eluting Stent Restenosis State of the Art: Causes, Evaluation, and Treatment

How Was the Case Treated

Case Presentation Before Treatment: An Unexpected and Difficult to Treat Stent Thrombosis

Are There Differences in the Outcomes of Early, Late, and Very Late Stent Thrombosis?

New Insights Into Neoatherosclerosis as a Frequent Common Denominator of DES Failure

Stent Thrombosis Update: Causes, Predictors, Implications, and Treatment

How Was This Patient Treated?

Debate: Should Most Patients With Stable Ischemic Heart Disease, Moderate or Greater Ischemia, and Controllable Symptoms Undergo Revascularization? Yes, an Evidence-Based Position!

Debate: Should Most Patients With Stable Ischemic Heart Disease, Moderate or Greater Ischemia, and Controllable Symptoms Undergo Revascularization? The Data Says Not as a First-Line Therapy!

Case Presentation: Pretreatment A Patient With Class II Angina and Anterior Wall Ischemia

How the Case Was Treated

Case Presentation Pretreatment: MVD Disease With Intermediate SYNTAX Score: How Should This Patient Be Treated?

Assessment and Implications of Surgical Inoperability: Who Is at High Risk?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content